Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 3
2008 1
2017 1
2018 1
2020 1
2021 1
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Detection of SARMs in doping control analysis.
Thevis M, Schänzer W. Thevis M, et al. Mol Cell Endocrinol. 2018 Mar 15;464:34-45. doi: 10.1016/j.mce.2017.01.040. Epub 2017 Jan 27. Mol Cell Endocrinol. 2018. PMID: 28137616 Review.
Doping control analytical approaches predominantly rely on chromatography hyphenated to mass spectrometry, which have allowed for appropriately covering the considerable variety of pharmacophores present in SARMs such as the non-steroidal representatives ACP-105, BMS-564929, GLPG …
Doping control analytical approaches predominantly rely on chromatography hyphenated to mass spectrometry, which have allowed for appropriat …
Identification of equine in vitro metabolites of seven non-steroidal selective androgen receptor modulators for doping control purposes.
Cutler C, Viljanto M, Taylor P, Hincks P, Biddle S, Van Eenoo P. Cutler C, et al. Drug Test Anal. 2022 Feb;14(2):349-370. doi: 10.1002/dta.3189. Epub 2021 Dec 10. Drug Test Anal. 2022. PMID: 34714606
In this study, the equine phase I metabolism of the non-steroidal SARMs GSK2881078, LGD-2226, LGD-3303, PF-06260414, ACP-105, RAD-140 and S-23 was investigated using equine liver microsomes. ...The equine metabolism of GSK-2881078, LGD-2226, …
In this study, the equine phase I metabolism of the non-steroidal SARMs GSK2881078, LGD-2226, LGD-3303, PF-06260414, AC …
Development of a multi-residue high-throughput UHPLC-MS/MS method for routine monitoring of SARM compounds in equine and bovine blood.
Ventura E, Gadaj A, Buckley T, Mooney MH. Ventura E, et al. Drug Test Anal. 2020 Sep;12(9):1373-1379. doi: 10.1002/dta.2875. Epub 2020 Jun 24. Drug Test Anal. 2020. PMID: 32519780
The presented screening method validation was performed in line with current EU legislation for the inspection of livestock and produce of animal origin, with detection capability (CCbeta) values determined at 0.5 ng/mL (Ly2452473), 1 ng/mL (AC-262536 and PF-06260414), 2 n …
The presented screening method validation was performed in line with current EU legislation for the inspection of livestock and produce of a …
Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
Thevis M, Kohler M, Maurer J, Schlörer N, Kamber M, Schänzer W. Thevis M, et al. Rapid Commun Mass Spectrom. 2007;21(21):3477-86. doi: 10.1002/rcm.3247. Rapid Commun Mass Spectrom. 2007. PMID: 17985352
Preventive approaches to restrict their use include early implementation of target analytes into doping control screening assays and evaluation of the mass spectrometric behavior of these drugs to allow their unequivocal identification as well as the characterization of structura …
Preventive approaches to restrict their use include early implementation of target analytes into doping control screening assays and evaluat …
Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator.
van Oeveren A, Motamedi M, Mani NS, Marschke KB, López FJ, Schrader WT, Negro-Vilar A, Zhi L. van Oeveren A, et al. J Med Chem. 2006 Oct 19;49(21):6143-6. doi: 10.1021/jm060792t. J Med Chem. 2006. PMID: 17034117
However, currently available androgens have many drawbacks. We identified 6-dialkylamino-4-trifluoromethylquinolin-2(1H)-ones as orally available tissue-selective androgen receptor modulators....
However, currently available androgens have many drawbacks. We identified 6-dialkylamino-4-trifluoromethylquinolin-2